胸腔內科

研究成果

篩選
快報
2 引文 斯高帕斯(Scopus)

Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?

Chang, C. H., Lee, C. H. & Wang, J. Y., 四月 20 2017, 於 : Journal of Clinical Oncology. 35, 12, p. 1374 1 p.

研究成果: 雜誌貢獻快報

3 引文 斯高帕斯(Scopus)
13 引文 斯高帕斯(Scopus)

Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly

Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 三月 1 2019, 於 : The European respiratory journal. 53, 3

研究成果: 雜誌貢獻快報

開啟存取
2 引文 斯高帕斯(Scopus)

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan

Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 八月 1 2017, 於 : The European respiratory journal. 50, 2

研究成果: 雜誌貢獻快報

10 引文 斯高帕斯(Scopus)

Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer

Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 十一月 2009, 於 : Onkologie. 32, 11, p. 685-686 2 p.

研究成果: 雜誌貢獻快報